Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Accuracy of Suppression of Tumorigenicity 2 Dynamics in Ischemic Stroke Outcome

NCT04607031 is registered in ClinicalTrials.gov with General Hospital Sveti Duh as lead sponsor.

NCT NCT04607031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Accuracy of Suppression of Tumorigenicity 2 Dynamics in Ischemic Stroke Outcome
Lead sponsor
General Hospital Sveti Duh
Phase
Observational
Overall status
Completed
Start date
September 10, 2019
Completion date
March 31, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke